Skip to main content
. 2021 Jul 25;38(1):183–193. doi: 10.1007/s10554-021-02359-0

Table 1.

Characteristics of the study populations

Development/internal validation sample External validation sample
Men
n = 1170
Women
n = 1084
Men
n = 50
Women
n = 64
Characteristics
 Age (years) 55.8 ± 6.1 55.5 ± 5.8 56.8 ± 9.0 53.3 ± 9.1
 Length (m) 1.81 ± 0.07 1.66 ± 0.06 1.77 ± 0.07 1.63 ± 0.07
 Weight (kg) 95.8 ± 12.7 81.5 ± 14.3 86.9 ± 15.8 73.3 ± 14.6
 BMI (kg/m2) 29.3 ± 3.4 29.4 ± 4.9 27.6 ± 4.2 27.7 ± 5.5
 BSA (m2) 2.19 ± 0.17 1.93 ± 0.19 2.06 ± 0.21 1.81 ± 0.19
 Total body fat (%) 28.4 ± 5.6 41.3 ± 6.0 26.0 ± 5.2 39.4 ± 7.4
 Systolic blood pressure (mmHg) 136.7 ± 15.3 128.4 ± 17.3 138.3 ± 14.8 132.9 ± 21.8
 Diastolic blood pressure (mmHg) 86.3 ± 10.1 83.7 ± 10.3 87.8 ± 9.6 80.5 ± 9.9
 Heart rate (beats/min) 67.7 ± 10.9 70.7 ± 10.6 69.7 ± 11.3 72.8 ± 13.0
 Pulse wave velocity (m/s) 6.6 ± 1.2 6.7 ± 1.3 8.2 ± 1.8 7.4 ± 1.9
Smoking (%)
 Never 413 (35.3) 432 (39.9) 27 (54.0) 44 68.8)
 Former 558 (47.7) 533 (49.2) 5 (10.0) 8 (12.5)
 Current 199 (17.0) 119 (11.0) 18 (36.0) 12 (18.8)
 Pack years 11.3 ± 16.0 8.6 ± 13.3 5.0 ± 10.6 3.9 ± 9.3
Glucose lowering medication (%)
 No 1113 (95.1) 1052 (97.0) 21 (42.0) 30 (46.9)
 Oral medication 44 (3.8) 27 (2.5) 13 (26.0) 9 (14.1)
 Insulin 4 (0.3) 1 (0.1) 0 (0) 1 (0)
 Oral medication and insulin 9 (0.8) 4 (0.4) 16 (32.0) 25 (39.1)
 Lipid lowering medication (%) 169 (14.4) 91 (8.4) 25 (50.0) 22 (34.4)
 Medication for hypertension (%) 301 (25.7) 277 (25.6) 21 (42.0) 22 (34.4)
 Total cholesterol (mmol/L) 5.64 ± 1.05 5.85 ± 1.09 5.09 ± 1.23 5.02 ± 1.05
 Triglycerides (mmol/L) 1.63 ± 1.03 1.27 ± 0.74 1.59 ± 1.47 1.46 ± 0.94
 HDL (mmol/L) 1.26 ± 0.32 1.62 ± 0.42 1.37 ± 0.37 1.57 ± 0.48
 LDL (mmol/L) 3.63 ± 0.96 3.65 ± 1.01 2.95 ± 1.12 2.78 ± 0.90
 Glucose (mmol/L) 5.78 ± 1.16 5.53 ± 0.89 6.84 ± 2.19 6.52 ± 2.22
 HbA1c (%) 5.45 ± 0.60 5.40 ± 0.42 7.07 ± 1.59 6.85 ± 1.55
 Creatinine (umol/L) 86.1 ± 14.2 69.5 ± 10.6 84.1 ± 15.6 61.2 ± 9.2

Data are shown as n (%) or mean ± SD

BMI body mass index, BSA body surface area, HDL high-density lipoprotein, LDL low-density lipoprotein